Literature DB >> 24286856

Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes.

Robert A Egnatchik1, Alexandra K Leamy1, Yasushi Noguchi2, Masakazu Shiota3, Jamey D Young4.   

Abstract

OBJECTIVE: Hepatic lipotoxicity is characterized by reactive oxygen species (ROS) accumulation, mitochondrial dysfunction, and excessive apoptosis, but the precise sequence of biochemical events leading to oxidative damage and cell death remains unclear. The goal of this study was to delineate the role of mitochondrial metabolism in mediating hepatocyte lipotoxicity. MATERIALS/
METHODS: We treated H4IIEC3 rat hepatoma cells with free fatty acids in combination with antioxidants and mitochondrial inhibitors designed to block key events in the progression toward apoptosis. We then applied (13)C metabolic flux analysis (MFA) to quantify mitochondrial pathway alterations associated with these treatments.
RESULTS: Treatment with palmitate alone led to a doubling in oxygen uptake rate and in most mitochondrial fluxes. Supplementing culture media with the antioxidant N-acetyl-cysteine (NAC) reduced ROS accumulation and caspase activation and partially restored cell viability. However, (13)C MFA revealed that treatment with NAC did not normalize palmitate-induced metabolic alterations, indicating that neither elevated ROS nor downstream apoptotic events contributed to mitochondrial activation. To directly limit mitochondrial metabolism, the complex I inhibitor phenformin was added to cells treated with palmitate. Phenformin addition eliminated abnormal ROS accumulation, prevented the appearance of apoptotic markers, and normalized mitochondrial carbon flow. Further studies revealed that glutamine provided the primary fuel for elevated mitochondrial metabolism in the presence of palmitate, rather than fatty acid beta-oxidation, and that glutamine consumption could be reduced through co-treatment with phenformin but not NAC.
CONCLUSION: Our results indicate that ROS accumulation in palmitate-treated H4IIEC3 cells occurs downstream of altered mitochondrial oxidative metabolism, which is independent of beta-oxidation and precedes apoptosis initiation.
© 2014.

Entities:  

Keywords:  2′-7′-dichlorodihydrofluorescein diacetate; BSA; CAC; Eto; FFA; GC-MS; H(2)DCFDA; Isotopomer modeling; Lipotoxicity; MFA; MUFA; Mass spectrometry; Metabolic flux analysis; N-acetyl cysteine; NAC; NAFLD; NASH; OA; PA; PHEN; PI; ROS; Reactive oxygen species; SFA; bovine serum albumin; citric acid cycle; etomoxir; free fatty acid; gas chromatography–mass spectrometry; metabolic flux analysis; monounsaturated fatty acid; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; oleate; palmitate; phenformin; propidium iodide; reactive oxygen species; saturated fatty acid.

Mesh:

Substances:

Year:  2013        PMID: 24286856      PMCID: PMC3946971          DOI: 10.1016/j.metabol.2013.10.009

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  37 in total

1.  Bidirectional reaction steps in metabolic networks: III. Explicit solution and analysis of isotopomer labeling systems.

Authors:  W Wiechert; M Möllney; N Isermann; M Wurzel; A A de Graaf
Journal:  Biotechnol Bioeng       Date:  1999       Impact factor: 4.530

2.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

3.  The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways.

Authors:  Dan Gao; Shanwei Nong; Xiuqing Huang; Yonggang Lu; Hongye Zhao; Yajun Lin; Yong Man; Shu Wang; Jiefu Yang; Jian Li
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

4.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

Authors:  A J Sanyal; C Campbell-Sargent; F Mirshahi; W B Rizzo; M J Contos; R K Sterling; V A Luketic; M L Shiffman; J N Clore
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

5.  Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease.

Authors:  Nishanth E Sunny; Elizabeth J Parks; Jeffrey D Browning; Shawn C Burgess
Journal:  Cell Metab       Date:  2011-12-07       Impact factor: 27.287

6.  Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver.

Authors:  Santhosh Satapati; Nishanth E Sunny; Blanka Kucejova; Xiaorong Fu; Tian Teng He; Andrés Méndez-Lucas; John M Shelton; Jose C Perales; Jeffrey D Browning; Shawn C Burgess
Journal:  J Lipid Res       Date:  2012-04-09       Impact factor: 5.922

7.  Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.

Authors:  Joel E Lavine; Jeffrey B Schwimmer; Mark L Van Natta; Jean P Molleston; Karen F Murray; Philip Rosenthal; Stephanie H Abrams; Ann O Scheimann; Arun J Sanyal; Naga Chalasani; James Tonascia; Aynur Ünalp; Jeanne M Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

8.  Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation.

Authors:  Simon A Hawley; Fiona A Ross; Cyrille Chevtzoff; Kevin A Green; Ashleigh Evans; Sarah Fogarty; Mhairi C Towler; Laura J Brown; Oluseye A Ogunbayo; A Mark Evans; D Grahame Hardie
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

Review 9.  Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.

Authors:  Alexandra K Leamy; Robert A Egnatchik; Jamey D Young
Journal:  Prog Lipid Res       Date:  2012-11-23       Impact factor: 16.195

10.  Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis.

Authors:  Yuki Kita; Toshinari Takamura; Hirofumi Misu; Tsuguhito Ota; Seiichiro Kurita; Yumie Takeshita; Masafumi Uno; Naoto Matsuzawa-Nagata; Ken-Ichiro Kato; Hitoshi Ando; Akio Fujimura; Koji Hayashi; Toru Kimura; Yinhua Ni; Toshiki Otoda; Ken-ichi Miyamoto; Yoh Zen; Yasuni Nakanuma; Shuichi Kaneko
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more
  53 in total

1.  Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells.

Authors:  Alexandra K Leamy; Robert A Egnatchik; Masakazu Shiota; Pavlina T Ivanova; David S Myers; H Alex Brown; Jamey D Young
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

2.  Sulfuretin protects hepatic cells through regulation of ROS levels and autophagic flux.

Authors:  Yu-Ting Lu; Yu-Feng Xiao; Yu-Feng Li; Jia Li; Fa-Jun Nan; Jing-Ya Li
Journal:  Acta Pharmacol Sin       Date:  2018-12-18       Impact factor: 6.150

3.  Short-term starvation is a strategy to unravel the cellular capacity of oxidizing specific exogenous/endogenous substrates in mitochondria.

Authors:  Julianna D Zeidler; Lorena O Fernandes-Siqueira; Ana S Carvalho; Eduardo Cararo-Lopes; Matheus H Dias; Luisa A Ketzer; Antonio Galina; Andrea T Da Poian
Journal:  J Biol Chem       Date:  2017-06-29       Impact factor: 5.157

4.  High fat diet disrupts endoplasmic reticulum calcium homeostasis in the rat liver.

Authors:  Emily S Wires; Kathleen A Trychta; Susanne Bäck; Agnieszka Sulima; Kenner C Rice; Brandon K Harvey
Journal:  J Hepatol       Date:  2017-07-17       Impact factor: 25.083

5.  Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Giovanni LoGrasso; Julia A Haidar; Justin J Dolkowski; Stephen I Lentz; Eva L Feldman
Journal:  J Lipid Res       Date:  2018-11-15       Impact factor: 5.922

6.  Knockdown of triglyceride synthesis does not enhance palmitate lipotoxicity or prevent oleate-mediated rescue in rat hepatocytes.

Authors:  Alexandra K Leamy; Clinton M Hasenour; Robert A Egnatchik; Irina A Trenary; Cong-Hui Yao; Gary J Patti; Masakazu Shiota; Jamey D Young
Journal:  Biochim Biophys Acta       Date:  2016-05-29

7.  Ezetimibe in the balance: can cholesterol-lowering drugs alone be an effective therapy for NAFLD?

Authors:  Giovanni Musso
Journal:  Diabetologia       Date:  2014-02-20       Impact factor: 10.122

8.  Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death.

Authors:  Constance Ahowesso; Paul N Black; Nipun Saini; David Montefusco; Jessica Chekal; Chrysa Malosh; Craig W Lindsley; Shaun R Stauffer; Concetta C DiRusso
Journal:  Biochem Pharmacol       Date:  2015-09-21       Impact factor: 5.858

9.  Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer.

Authors:  Fredrick T Harris; S M Jamshedur Rahman; Mohamed Hassanein; Jun Qian; Megan D Hoeksema; Heidi Chen; Rosana Eisenberg; Pierre Chaurand; Richard M Caprioli; Masakazu Shiota; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-12

10.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

Authors:  Santhosh Satapati; Blanka Kucejova; Joao A G Duarte; Justin A Fletcher; Lacy Reynolds; Nishanth E Sunny; Tianteng He; L Arya Nair; Kenneth A Livingston; Kenneth Livingston; Xiaorong Fu; Matthew E Merritt; A Dean Sherry; Craig R Malloy; John M Shelton; Jennifer Lambert; Elizabeth J Parks; Ian Corbin; Mark A Magnuson; Jeffrey D Browning; Shawn C Burgess
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.